SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sientra, Inc. – SIEN

NEW YORK, NY / ACCESSWIRE / September 24, 2015 / Pomerantz LLP is investigating claims on behalf of investors of Sientra, Inc. (“Sientra” or the “Company”) (NASDAQ: SIEN). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 9980.

The investigation concerns whether Sientra and certain of its officers and/or directors have violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934. 

On September 24, 2015, it was announced that the United Kingdom’s Medicines and Healthcare Products Regulatory Agency (MHRA) had suspended sales of Sientra’s Silimed-brand silicone breast implants following the discovery of contamination in the company’s Rio De Janeiro manufacturing plant. 

On this news, Sientra’s stock has fallen as much as $11.20, or 54.4%, during intraday trading on September 24, 2015.

The Pomerantz Firm, with offices in New York, Chicago, Los Angeles, and Florida, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 70 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com.

SOURCE: Pomerantz LLP 

ReleaseID: 432197